decisionhealth Newsletters, Coder Pink Sheets - 2002 Issue 1 (January)
New drug fee schedule has varied effect, depending on area
Subscribe or sign in to view the full article.
Article Overview
This piece covers a Medicare update to the drug fee schedule and its impact on reimbursement for office-administered injectables, with particular relevance to practices that commonly furnish these drugs. It is useful for billing and coding staff, practice managers, and orthopedic or similar specialty offices that need to understand the general scope of the pricing change and the coding references mentioned in the article.
Why This Topic Matters
Changes to drug payment methodology can alter reimbursement expectations, cash flow, and charge capture for office-supplied medications. Readers can use this article to identify the affected setting, the policy context, and the general category of injectable drug coding discussed.
What You Will Learn
- What policy change the article is discussing
- How the update is positioned as affecting office-supplied injectable drugs
- Which broad drug-related coding topics are referenced in the reimbursement discussion
- Why geographic payment variation is relevant to the article's audience
Who Should Read This
- Medical coders
- Billing staff
- Practice managers
- Orthopedic practices
- Physician offices billing Medicare
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com